Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

28.07 -0.23 (-0.80%)
Streaming Delayed Price Updated: 10:47 AM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
News headline image
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
From Pfizer Inc.
Via Business Wire
News headline image
Have $500? 2 Healthcare Stocks Long-Term Investors Should Buy Right Now ↗
You can get in on these market giants for bargain prices today. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Unpopular Stocks That Should Get More Attention and 1 We Avoid
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t... 
Via StockStory
Topics Supply Chain
Pfizer Inc. (NYSE:PFE) Shows Strong Technical Setup for Potential Breakout ↗
Via Chartmill
News headline image
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
From Pfizer Inc.
Via Business Wire
News headline image
My Top 3 Drug Stocks for March 2026 ↗
These companies have impressive track records of navigating the biggest challenges in their industry. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗
They aren't just "pandemic stocks." 
Via The Motley Fool
Topics Intellectual Property
Which S&P500 stocks are the most active on Thursday? ↗
Via Chartmill
News headline image
Follow the Footprints: 3 Stocks with Unusual Options Activity That You Can’t Ignore
On a day when nothing worked for investors, yesterday’s unusual options activity had plenty of variety, especially in the top three. Here’s how investors might have played each of the stock's and their... 
Via Barchart.com
Topics Economy Stocks
News headline image
Is It Too Late to Buy Eli Lilly? ↗
Eli Lilly's GLP-1 drugs are leaders in a new and exciting drug category, but investors already know this fact. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Looking for Safety and Yield as Oil Prices Whip Saw? This Stock Has You Covered.
As oil prices rise with increasing global uncertainty, this pharmaceutical stock emerges as a possible safe haven for income investors. 
Via Barchart.com
Topics Earnings
News headline image
Pfizer Combo Therapy Scores Major Win In Prostate Cancer Trial ↗
Pfizer (PFE) shares rise as Talzenna/Xtandi combo hits primary goal in Phase 3 prostate cancer trial. See the full TALAPRO-3 results. 
Via Benzinga
News headline image
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
From Pfizer Inc.
Via Business Wire
Looking for the most active stocks in the S&P500 index on Wednesday? ↗
Via Chartmill
News headline image
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
The Best Healthcare Stocks to Buy With $50 Right Now ↗
Even on a budget, you can get quality stocks. 
Via The Motley Fool
News headline image
Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Zoetis (NYSE:ZTS)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Zoetis (NYSE:ZTS) and its peers. Looking ... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Tuesday's session: most active stock in the S&P500 index ↗
Via Chartmill
News headline image
The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump
As the first quarter of 2026 draws to a close, the S&P 500 is witnessing one of the most dramatic sector performance splits in recent financial history. According to consensus estimates as of March 17,... 
Via MarketMinute
Topics Earnings Economy Initial Public Offering
News headline image
Pfizer Touts Promising Survival Data Without Worsening For Advanced Breast Cancer Patients ↗
Pfizer trial results for a new breast cancer treatment showed improved progression-free survival and a manageable safety profile. 
Via Benzinga
News headline image
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Should You Avoid Pfizer? Here's the Key Risk to Watch ↗
Pfizer has reached a turning point. 
Via The Motley Fool
Topics Intellectual Property
News headline image
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
The biotech sector has found its new North Star in 2026. As of mid-March, Moderna Inc. (NASDAQ: MRNA) has shocked Wall Street with a staggering 83% year-to-date gain, catapulting it to the upper... 
Via MarketMinute
Topics Artificial Intelligence Initial Public Offering Stocks
News headline image
VCIT Offers Broader Diversification Than FIGB ↗
Explore how differences in cost, risk, and portfolio breadth could impact your choice between these two bond ETFs. 
Via The Motley Fool
Topics Bonds ETFs
News headline image
Rushing Headlong: Health IT's Legacy and the Road to Responsible AI Named 2025 Foreword INDIES Book of the Year Awards Finalist
Via PRLog
Topics Artificial Intelligence
News headline image
Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026
Amidst a backdrop of mounting geopolitical tensions and sharp swings in the broader indices, pharmaceutical giant Merck & Co. (NYSE: MRK) officially trades ex-dividend today, March 16, 2026. Investors... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
3 Monster Dividend Stocks to Hold for the Next 10 Years ↗
These dividend stocks are built for the long haul. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
The Stock Market May Be Shifting From Risky Tech Stocks to Safer Sectors. Here Are 3 Stocks to Buy Before They Soar. ↗
Plenty of companies do just fine regardless of the economic environment. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. ↗
Via Chartmill
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.